Page last updated: 2024-12-10

rhodoxanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rhodoxanthin: RN given refers to (all-trans)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5281251
CHEBI ID8835
SCHEMBL ID42598
MeSH IDM0114749

Synonyms (16)

Synonym
LMPR01070280
C08610
rhodoxanthin
116-30-3
(4e)-3,5,5-trimethyl-4-[(2e,4e,6e,8e,10e,12e,14e,16e,18e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-4-oxocyclohex-2-en-1-ylidene)octadeca-2,4,6,8,10,12,14,16-octaenylidene]cyclohex-2-en-1-one
4,5'-retro-beta,beta-carotene-3,3'-dione, 4',5'-didehydro-
51v984id9q ,
unii-51v984id9q
e-161f
4,7'-retro-.beta.,.epsilon.-carotene-3,3'-dion
rhodoxanthin [mi]
SCHEMBL42598
VWXMLZQUDPCJPL-ZDHAIZATSA-N
CHEBI:8835
Q2479965
DTXSID201017050

Research Excerpts

Overview

Rhodoxanthin is a scarcely explored carotenoid. It has an extraordinarily large chromophore and high potential to function as red pigment.

ExcerptReferenceRelevance
"Rhodoxanthin is a scarcely explored carotenoid with an extraordinarily large chromophore and high potential to function as red pigment. "( The impact of (E/Z)-isomerization and aggregation on the color of rhodoxanthin formulations for food and beverages.
Bonrath, W; Schäfer, C; Schex, R; Schweiggert, R, 2020
)
2.24
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
xanthophyllA subclass of carotenoids consisting of the oxygenated carotenes.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (15.38)18.7374
1990's0 (0.00)18.2507
2000's6 (46.15)29.6817
2010's2 (15.38)24.3611
2020's3 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.02 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]